Skip to main content
. 2011 Apr 18;4:43–48. doi: 10.2147/CEG.S18051

Figure 2.

Figure 2

Percentage of patients obtaining ≥50% best global improvement following rifaximin treatment. Global symptoms improved in 79 of 162 patients (49%) who received rifaximin 1200 mg/day for 10 days compared with 38 of 81 patients (47%) who received high-dose rifaximin (2400 mg/day) for 10 days.

Note: aIncludes patients who received additional high-dose rifaximin therapy.